Which to pill to try. Advice please! 1/21/2026
The conversation is about hair loss treatments, specifically discussing the use of minoxidil, finasteride, and dutasteride. The advice suggests continuing minoxidil and considering dutasteride or finasteride as DHT blockers, with a focus on managing potential shedding and side effects.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 14 months on Fin, Total T 899, serum DHT 276 — high total T may still drive scalp DHT even when blood levels look controlled
A 23-year-old male has been using finasteride and topical minoxidil for 14 months with slight improvement, but recent shedding led him to switch to a new minoxidil formulation without success. He is considering using topical RU58841 or dutasteride to better address scalp DHT, as his bloodwork shows high total testosterone and mid-range DHT levels.
community Dutasteride Literally Saves Your Hair
Dutasteride significantly reduces scalp DHT levels and can save hair, though shedding is part of the process. Some users report success with dutasteride, while others struggle despite using it along with finasteride and oral minoxidil.
community Can someone explain the Dutasteride hysteria in this community?
The conversation is about the double standard in the hair loss community regarding shedding when using different treatments. The conclusion is that shedding is considered normal when starting finasteride or minoxidil, but not when starting dutasteride, despite the fact that dutasteride is more effective at reducing DHT.
community Massive Shedding and Itchy Scalp (Fin 1mg 4x/week, Dut 0.5mg 3x/week, Minoxidil 1ml 2x/day)—Seeking Advice
The user experienced significant hair shedding and an itchy scalp after using a combination of Finasteride, Dutasteride, and Minoxidil. They are seeking advice on whether Dutasteride might be causing these issues and are considering adjusting their treatment regimen.
community "Switched to Dutasteride and 7.5 mg Oral Minoxidil 4 Months Ago – Still Shedding?"
A 24-year-old switched from finasteride to dutasteride and increased oral minoxidil from 5 mg to 7.5 mg, noticing increased hair shedding. Users discuss the safety and effects of high-dose minoxidil, with some suggesting the shedding may be temporary due to dosage changes.
community DHT levels after 10 months on dut 0.5 ed, how is this even possible?
A user experienced accelerated hairline recession after adding dutasteride to their regimen of topical finasteride and minoxidil, despite reduced hair shedding. They were informed that ELISA testing for DHT levels can be highly inaccurate.
Related Research
6 / 6 results
research Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
research The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.
research Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
This review discusses the evaluation and management of male baldness and related conditions, but reports no new clinical results.
research Hair Biology
This review discusses various biologics for hair aging but reports no agent capable of reversing the natural aging process of hair.
research Male pattern baldness: current treatments, future prospects
This review addresses the limited efficacy of current treatments for male pattern baldness and explains that emerging genetic insights could lead to more effective future therapies.
research Updates in Treatment for Androgenetic Alopecia
This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.